Source:http://linkedlifedata.com/resource/pubmed/id/11594519
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-10-11
|
pubmed:abstractText |
The clinicopathological features of 10 patients with primary mediastinal large B-cell lymphoma (PMLBCL) are described. The patients were aged 19 to 63 years, with a median age of 25.5 years. There were 5 men and 5 women. All patients presented with chest symptoms, and 6 presented with superior vena cava syndrome. Nine patients had bulky mediastinal tumors. The disease was confined within the thorax and contiguous lymph nodes, although multiple liver tumors were observed in 1 patient. Laboratory findings included high lactate dehydrogenase levels and elevated C-reactive protein levels. The soluble interleukin 2-receptor level was high in 6 patients tested. A comparative study of PMLBCL and nodular sclerosis-type Hodgkin's disease (NS-HD) with a mediastinal mass revealed substantial overlap in clinical features. Histopathological examination of biopsy specimens of PMLBCL revealed clusters of CD20+ large cells; however, CD30+ Hodgkin/Reed-Sternberg-like cells were occasionally seen, raising the potential to misdiagnose PMLBCL as NS-HD. The patients with PMLBCL were treated with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone), biweekly CHOP, or MACOP-B (methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisolone, and bleomycin) regimen, and 6 received consolidation radiotherapy to the involved field. With the exception of 1 patient who was primarily refractory to therapy, 9 patients (90%) achieved complete response and 7 (70%) remain in continuous remission with a mean follow-up of 24 months.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0925-5710
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
178-85
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11594519-Adult,
pubmed-meshheading:11594519-Antigens, CD20,
pubmed-meshheading:11594519-Antigens, CD30,
pubmed-meshheading:11594519-Antigens, Neoplasm,
pubmed-meshheading:11594519-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11594519-Diagnosis, Differential,
pubmed-meshheading:11594519-Female,
pubmed-meshheading:11594519-Hodgkin Disease,
pubmed-meshheading:11594519-Humans,
pubmed-meshheading:11594519-Lymph Nodes,
pubmed-meshheading:11594519-Lymphoma, B-Cell,
pubmed-meshheading:11594519-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:11594519-Male,
pubmed-meshheading:11594519-Mediastinal Neoplasms,
pubmed-meshheading:11594519-Middle Aged,
pubmed-meshheading:11594519-Sclerosis,
pubmed-meshheading:11594519-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease.
|
pubmed:affiliation |
Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|